Directory for innovators
The AHSN Network can provide you with valuable support in accessing funding opportunities and developing successful partnerships. We lead large regional networks, and our impact rests in our ability to bring people, resources and organisations together, delivering benefits that could not be achieved alone.Sign up to our funding newsletter
Find your nearest AHSN
Search our directoryWhat is my nearest AHSN?
Biomedical catalyst 2021: early and late stage awards
UK registered businesses can apply for a share of up to £18 million to develop innovative healthcare products, technologies and processes. This funding is from Innovate UK, part of UK Research and Innovation. Your project can address: -disease prevention and proactive management of health and chronic conditions -earlier and better detection and diagnosis of disease, leading to better patient outcomes -tailored treatments that either change the underlying disease or offer potential cures This list is not intended to be exhaustive. This competition combines the early and late-stage strands of the Biomedical Catalyst. Equality, diversity and inclusion (EDI) considerations are highly encouraged where appropriate in the proposal. Applications will continue to be assessed on their innovation merit, where innovation is defined as the potential for commercially successful exploitation of ideas. In applying to this competition, you are entering into a competitive process This competition closes Thursday 26 August 2021 11am UK time on the date of the deadline.
Pre-announcement: experimental medicine grants: Sep 2021
Opening date: 15 July 2021 Closing date: 9 September 2021 16:00 Apply for funding to investigate the causes, progression and treatment of human disease. Your project must: * include an experimental intervention or challenge in humans * focus on addressing mechanistic questions * be academically led.
The Health Technology Assessment (HTA) Programme.
Closing date: 1pm, 5 May 2021 Proposals should normally evaluate the clinical and cost effectiveness of a health technology. For diagnostic technologies, researchers may suggest equivalent evaluations. We are interested in receiving proposals addressing any health problem in areas not otherwise well covered in our portfolio. Please note that proposals should be within the scope of the HTA Programme. Proposals to investigate the organisation of health services, or services entirely outside the NHS will not be eligible.
Expression of interest: transforming UK food systems for health and environment
Closing date: 22 April 2021 16:00 Apply for funding to support interdisciplinary research into interventions that will transform the UK food system. Your project should bring together elements from both of these areas: * production, processing, manufacturing, food environments * healthier diets and consumption.
Artificial Intelligence and Racial and Ethnic Inequalities in Health and Care call
The call opens on Wednesday 24 March 2021. The deadline for applications is 13:00 on Wednesday 21 April 2021. The Artificial Intelligence and Racial and Ethnic Inequalities in Health and Care call will support research to advance artificial intelligence (AI) and data-driven technologies in health in ways that better meet the needs of minority ethnic populations. The call, which is part of the NHSX's NHS AI Lab AI Ethics Initiative, will fund two categories of research: 1. Understanding and enabling the opportunities to use AI to address inequalities Funded by The Health Foundation Awards of £175,000 to £275,000 2. Optimisingdatasets, and improving AI development, testing and deployment Funded by the NHSX’s NHS AI Lab Awards of £200,000 to £500,000
Expression of interest: emergency route for time-critical Covid-19 research
Opportunity status: Open Funders: UK Research and Innovation Funding type: Grant Maximum award: £80,000 Publication date: 6 January 2021 Opening date: 5 January 2021 Closing date: Open - no closing date This is a rarely awarded emergency route for exceptional circumstances. The normal route to apply for support for Covid-19 research is through existing standard funding opportunities.
Greater Manchester Research and Innovation Health Accelerator
A new accelerator programme is inviting SMEs to collaborate with Greater Manchester’s research and innovation institutions to support the development of innovative health and care products. The Research and Innovation (R&I) Health Accelerator is open to companies looking to accelerate commercialisation of their product or service into the health and care system. As part of the R&I Health Accelerator, SMEs will be able to access expertise, funding and support to help progress their products and services towards adoption and commercialisation in the health and care system.
£300,000 funding and support programme available for companies with innovative healthcare solutions
Health Innovation Manchester has opened applications for the 2020-2021 Momentum Innovation Fund. The innovation fund has been established to support the introduction and adoption of needs-led, evidence-based innovations into the healthcare system within Greater Manchester and East Cheshire. HInM has also partnered with Danaher Diagnostics on a health accelerator programme to support innovations that provide remote management of patients leaving hospital care and/or patients with long-term conditions at home.
NIHR i4i Product Development Awards Call 21 will open on 20 October 2020.
i4i Product Development Awards (PDA) support innovations at any stage of the translational research and development pathway, including the clinical development of laboratory-validated technologies or interventions.
Innovate UK Smart Grants: Competition closes - Wednesday 25 November 2020 11:00am
Opportunity for UK registered organisations to apply for a share of up to £25 million from Innovate UK to deliver disruptive R&D innovations that can significantly impact the UK economy. Smart is Innovate UK’s ‘Open grant funding’ programme.
The application period for the NHS Innovation Accelerator (NIA) is now open. Closing date 16 October 2020
We are now recruiting for individuals representing high impact, evidence-based innovations that address one or more of this year’s themes: * NHS response to Covid-19 * Mental health * Supporting the NHS workforce
DASA: Biosensing across wide areas. Deadline: 1 June 2020
DASA is looking for solutions to detect and locate deposited hazardous biological agents rapidly in the field. Proposals will need to deliver a higher level of maturity than achieved in Phase 1. We expect the starting Technology Readiness Level (TRL) of the innovation to be TRL 3. By the end of the project, we expect the innovation to be sufficiently developed to achieve approximately TRL 4 – 5. £700k is available to fund Phase 2